These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 7906506

  • 21. Syntheses and biological activity of C-3'-difluoromethyl-taxoids.
    Ojima I, Lin S, Slater JC, Wang T, Pera P, Bernacki RJ, Ferlini C, Scambia G.
    Bioorg Med Chem; 2000 Jul; 8(7):1619-28. PubMed ID: 10976509
    [Abstract] [Full Text] [Related]

  • 22. The farnesyl protein transferase inhibitor SCH66336 synergizes with taxanes in vitro and enhances their antitumor activity in vivo.
    Shi B, Yaremko B, Hajian G, Terracina G, Bishop WR, Liu M, Nielsen LL.
    Cancer Chemother Pharmacol; 2000 Jul; 46(5):387-93. PubMed ID: 11127943
    [Abstract] [Full Text] [Related]

  • 23. Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells.
    Ehrlichova M, Vaclavikova R, Ojima I, Pepe A, Kuznetsova LV, Chen J, Truksa J, Kovar J, Gut I.
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):95-105. PubMed ID: 16059735
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of antitumour effects of docetaxel (Taxotere) on human gastric cancers in vitro and in vivo.
    Tanaka M, Obata T, Sasaki T.
    Eur J Cancer; 1996 Feb; 32A(2):226-30. PubMed ID: 8664032
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Orally active docetaxel analogue: synthesis of 10-deoxy-10-C-morpholinoethyl docetaxel analogues.
    Iimura S, Uoto K, Ohsuki S, Chiba J, Yoshino T, Iwahana M, Jimbo T, Terasawa H, Soga T.
    Bioorg Med Chem Lett; 2001 Feb 12; 11(3):407-10. PubMed ID: 11212122
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Differential impact of Raf-1 kinase activity on tumor cell resistance to paclitaxel and docetaxel.
    Britten RA, Klein K.
    Anticancer Drugs; 2000 Jul 12; 11(6):439-43. PubMed ID: 11001384
    [Abstract] [Full Text] [Related]

  • 30. Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells.
    Hennequin C, Giocanti N, Favaudon V.
    Cancer Res; 1996 Apr 15; 56(8):1842-50. PubMed ID: 8620502
    [Abstract] [Full Text] [Related]

  • 31. Paclitaxel- and docetaxel-dependent activation of CA-125 expression in human ovarian carcinoma cells.
    Marth C, Zeimet AG, Widschwendter M, Ludescher C, Kaern J, Tropé C, Gastl G, Daxenbichler G, Dapunt O.
    Cancer Res; 1997 Sep 01; 57(17):3818-22. PubMed ID: 9288793
    [Abstract] [Full Text] [Related]

  • 32. hTERT gene expression levels and telomerase activity in drug resistant MCF-7 cells.
    Sakin V, Eskiocak U, Kars MD, Iseri OD, Gunduz U.
    Exp Oncol; 2008 Sep 01; 30(3):202-5. PubMed ID: 18806742
    [Abstract] [Full Text] [Related]

  • 33. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.
    Mason KA, Kishi K, Hunter N, Buchmiller L, Akimoto T, Komaki R, Milas L.
    Clin Cancer Res; 1999 Dec 01; 5(12):4191-8. PubMed ID: 10632360
    [Abstract] [Full Text] [Related]

  • 34. Synergistic antiproliferative activity of tamoxifen and docetaxel on three oestrogen receptor-negative cancer cell lines is mediated by the induction of apoptosis.
    Ferlini C, Scambia G, Distefano M, Filippini P, Isola G, Riva A, Bombardelli E, Fattorossi A, Benedetti Panici P, Mancuso S.
    Br J Cancer; 1997 Dec 01; 75(6):884-91. PubMed ID: 9062411
    [Abstract] [Full Text] [Related]

  • 35. Taxol and taxotere in bladder cancer: in vitro activity and urine stability.
    Rangel C, Niell H, Miller A, Cox C.
    Cancer Chemother Pharmacol; 1994 Dec 01; 33(6):460-4. PubMed ID: 7907952
    [Abstract] [Full Text] [Related]

  • 36. Peripheral benzodiazepine receptor ligands induce apoptosis and cell cycle arrest in human hepatocellular carcinoma cells and enhance chemosensitivity to paclitaxel, docetaxel, doxorubicin and the Bcl-2 inhibitor HA14-1.
    Sutter AP, Maaser K, Grabowski P, Bradacs G, Vormbrock K, Höpfner M, Krahn A, Heine B, Stein H, Somasundaram R, Schuppan D, Zeitz M, Scherübl H.
    J Hepatol; 2004 Nov 01; 41(5):799-807. PubMed ID: 15519653
    [Abstract] [Full Text] [Related]

  • 37. Docetaxel enhances the expression of E-cadherin and carcinoembryonic antigen (CEA) on human colon cancer cell lines in vitro.
    Eckert K, Fuhrmann-Selter T, Maurer HR.
    Anticancer Res; 1997 Nov 01; 17(1A):7-12. PubMed ID: 9066624
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Preclinical pharmacology of docetaxel.
    Bissery MC.
    Eur J Cancer; 1995 Nov 01; 31A Suppl 4():S1-6. PubMed ID: 7577097
    [Abstract] [Full Text] [Related]

  • 40. The scientific rationale for developing taxoids.
    Aapro M.
    Anticancer Drugs; 1996 Aug 01; 7 Suppl 2():33-6. PubMed ID: 8862709
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.